Animal Models of Huntington's Disease

Encyclopedia of Neuroscience

Volumn , Issue , 2009, Pages 429-436

  Alberch, J ^a   Perez Navarro E ^a   Canals, J M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

CAG repeats; Exon 1; Huntingtin; Intranuclear and intracytoplasmatic inclusions; Knockin; Motor activity; Striatum; Transgenic

Indexed keywords

EID: 84882921634     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008045046-9.00502-7     Document Type: Chapter

References (16)

1. Beal M.F., Ferrante R.J. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nature Reviews Neuroscience 2004, 5:373-384.
2. Canals J.M., Pineda J.R., Torres-Peraza J.F., et al. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. Journal of Neuroscience 2004, 24:7727-7739.
3. Diaz-Hernandez M., Torres-Peraza J., Salvatori-Abarca A., et al. Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease. Journal of Neuroscience 2005, 25:9773-9781.
4. Hodgson J.G., Agopyan N., Gutekunst C.A., et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 1999, 23:181-192.
5. Laforet G.A., Sapp E., Chase K., et al. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. Journal of Neuroscience 2001, 21:9112-9123.
6. Lin C.H., Tallaksen-Greene S., Chien W.M., et al. Neurological abnormalities in a knockin mouse model of Huntington's disease. Human Molecular Genetics 2001, 10:137-144.
7. Mangiarini L., Sathasivam K., Seller M., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
8. Menalled L.B., Chesselet M.F. Mouse models of Huntington's disease. Trends in Pharmacological Science 2002, 23:32-39.
9. Menalled L.B., Sison J.D., Dragatsis I., Zeitlin S., Chesselet M.F. Time course of early motor and neuropathological anomalies in a knockin mouse model of Huntington's disease with 140 CAG repeats. Journal of Comparative Neurology 2003, 465:11-26.
10. Menalled L.B., Sison J.D., Wu Y., et al. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knockin mice. Journal of Neuroscience 2002, 22:8266-8276.
11. Rubinsztein D.C. Lessons from animal models of Huntington's disease. Trends in Genetics 2002, 18:202-209.
12. Schilling G., Becher M.W., Sharp A.H., et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Human Molecular Genetics 1999, 8:397-407.
13. Slow E.J., van Raamsdonk J., Rogers D., et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Human Molecular Genetics 2003, 12:1555-1567.
14. Wheeler V.C., White J.K., Gutekunst C.A., et al. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knockin mice. Human Molecular Genetics 2000, 9:503-513.
15. Yamamoto A., Lucas J.J., Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 2000, 101:57-66.
16. The Hereditary Disease Foundation. http://www.hdfoundation.org.